Helissey, C., Naltet, C., Guezour, N., Bintein, F., Jouveshomme, S., TORCY, M. D., Helal, C., Marques, A., Schernberg, A., Raymond, E., Blanchardie, P., Blanchet, B. (2026). Patient-reported outcomes for identification of distinct tolerance phenotypes with differential survival impact under osimertinib in EGFR-mutated NSCLC.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e24178